ANEBULO PHARMACEUTICALS, INC.

ANEB ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
4 Apr 7, 2025
4 Apr 7, 2025
8-K Apr 7, 2025
SCHEDULE 13G Mar 17, 2025
ARS Mar 6, 2025
DEF 14A Mar 6, 2025
424B5 Mar 3, 2025
EFFECT Feb 28, 2025
SCHEDULE 13D/A Feb 27, 2025
CORRESP Feb 26, 2025
UPLOAD Feb 25, 2025
PRE 14A Feb 24, 2025
8-K Feb 24, 2025
S-3 Feb 20, 2025
SCHEDULE 13G Feb 14, 2025
10-Q Feb 14, 2025
8-K Feb 14, 2025
8-K Feb 12, 2025
D Dec 31, 2024
SCHEDULE 13D/A Dec 26, 2024
4 Dec 26, 2024
8-K Dec 23, 2024
4 Dec 10, 2024
10-Q Nov 13, 2024
8-K Nov 13, 2024
← Newer Page 3 of 9 · 204 filings Older →